EUVIMEDEUVIMED entdecken
Open Access

Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation

Shuhan Jin, Bo Li, Bibo Zhang, Xuejie Gao, Xinyan Jia, Li Xu, Shuaikang Chang, Ke Hu, Guanli Wang, Zhijian Xu, Ting Zhang, Dongliang Song und 8 weitere

Acta Biochimica et Biophysica Sinica · 2023

DOI: 10.3724/abbs.2023260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2023. Verfasst von Shuhan Jin und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaAntineoplastic AgentsHumansBortezomibPhosphatidylinositol 3-KinasesDrug Resistance, NeoplasmCell Line, TumorApoptosisCell ProliferationProteasome Endopeptidase ComplexSTAT3 Transcription FactorPentacyclic Triterpenes

Stichwörter der Autor:innen

JAK2/STAT3PSMB5bortezomib resistancedihydrocelastrolmultiple myeloma

Substanzen

BortezomibAntineoplastic AgentsPhosphatidylinositol 3-KinasesProteasome Endopeptidase ComplexSTAT3 Transcription FactorcelastrolPentacyclic TriterpenesPSMB5 protein, humanSTAT3 protein, human

Autor:innen und Institutionen

  • Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • State Key Laboratory of Drug Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Department of Hematology, the Affiliated People's Hospital of Ningbo University, Ningbo 315000, China.
  • Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.

Zitieren

APA

Jin, S., Li, B., Zhang, B., Gao, X., Jia, X., Xu, L., Chang, S., Hu, K., Wang, G., Xu, Z., Zhang, T., Song, D., Yang, G., Wu, X., Zhu, H., Huang, C., Lu, Y., Shi, J., Zhu, W., & Chen, G. (2023). Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2023260

Vancouver

Jin S, Li B, Zhang B, Gao X, Jia X, Xu L, et al. Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation. Acta Biochimica et Biophysica Sinica. 2023. doi:10.3724/abbs.2023260

BibTeX
@article{Jin2023,
  author = {Jin, Shuhan and Li, Bo and Zhang, Bibo and Gao, Xuejie and Jia, Xinyan and Xu, Li and Chang, Shuaikang and Hu, Ke and Wang, Guanli and Xu, Zhijian and Zhang, Ting and Song, Dongliang and Yang, Guang and Wu, Xiaosong and Zhu, Huabin and Huang, Cheng and Lu, Yumeng and Shi, Jumei and Zhu, Weiliang and Chen, Gege},
  title = {Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2023},
  doi = {10.3724/abbs.2023260}
}
Kostenlos starten →